Precautionary recall alert

Printer-friendly version
Recall alert for psoriasis product

In a precautionary recall measure, a treatment for psoriasis (Dovobet Gel - calcipotriol with betamethasone)  is included in the full list of products that are subject of an alert issued by The Medicines and Healthcare products Regulatory Agency (MHRA) . Other products are for patients taking certain types of prescription-only medicines for Parkinson’s (Neupro), epilepsy (Vimpat) and blood clots (Clexane)  patients are asked to check to see if they have products from batches of medicines which are being recalled. The medicines are believed to be legitimate but were taken out of the regulated medicines’ supply chain during distribution and later re-introduced. This means that the correct transport and storage conditions cannot be guaranteed during this period and, while unlikely, could impact their effectiveness. 

The medicines are stable at room temperature and there is no evidence that they were tampered with. This means that the risk of these medicines not being fully effective is greatly reduced or negligible. Therefore patients should continue taking their medicine.

Patients can check their medicines by looking for the affected batch numbers on B & S Healthcare labelled packs. The affected medicines are in the original Italian packaging with the UK manufacturer’s, B & S Healthcare, label. This recall relates only to B & S Healthcare labelled products.

The Medicines and Healthcare products Regulatory Agency (MHRA) has undertaken a medical assessment of the products to determine whether there is any risk to patients. As a precautionary measure, three medicines are being recalled to a patient level because in the very unlikely event that these products are not fully effective there is a potential risk to patient safety. For these three particular medicines, whilst the likelihood of their effectiveness being compromised is low (because they are stable legitimate medicines), the consequences of a lack of effectiveness could be serious which is why they are being recalled from patients.

If patients have any of these affected products, they should continue taking their medicines and contact their GP practice to arrange a new prescription. Once they have a new prescription, patients should return the affected batches to their pharmacist.

To check if you have an affected product, below are the included psoriasis products, batch numbers and dates. The alert is ONLY for those psoriasis products listed below, but if in doubt talk to your doctor or pharmacist, who will be able to advise you fully.
 

Product and Pack Size

Italian Batch Number

B & S Batch Number

Expiry Date

Date of First Distribution

Dovobet Gel 1 x 30g

A80960

11N0735

30-JUL-20

06-DEC-18

Dovobet Gel 1 x 30g

A79729

11N0734

30-JUN-20

05-DEC-18

Dovobet Gel 1 x 30g

A85747

01P0222

30-OCT-20

09-JAN-19

Dovobet Gel 1 x 30g

A78018

01P0850

30-MAY-20

16-JAN-19

Dovobet Gel 1 x 30g

A80960

01P0221

30-JUL-20

09-JAN-19

Dovobet Gel 1 x 30g

A87671

02P1199

30-OCT-20

02-APR-19

Dovobet Gel 1 x 30g

A85936

02P1206

30-OCT-20

19-MAR-19

Dovobet Gel 1 x 30g

A85747

02P1207

30-OCT-20

29-APR-19

Dovobet Gel 1 x 30g

A88301

02P1205

30-NOV-21

15-MAY-19

Dovobet Gel 1 x 30g

A80960

02P1204

30-JUL-20

30-APR-19

Dovobet Gel 1 x 30g

A89721

04P0609

30-NOV-21

14-MAY-19

Dovobet Gel 1 x 30g

A90279

03P1677

30-DEC-21

12-APR-19

Dovobet Gel 1 x 30g

A85936

03P1679

30-OCT-20

14-MAY-19

Read alert in full on the MHRA website.